$CTNM
Contineum Therapeutics, Inc. Class A Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$10.79
▲+2.13%+$0.225Market open
Contineum Therapeutics, Inc. Class A Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Flagged at $9.19 at 02:40 PM on Oct 12, then ran to $11.54 +26% that session.
The high is the session peak after our first alert, not a realized trade. Not investment advice.
Why is CTNM up today? It is at $10.79 (+2.13%), and our scanner flagged it 94 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CTNM spikes, and full due diligence on CTNM — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $CTNM 94 times in the last 30 days. Create a free account to track $CTNM, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on CTNM from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CTNM today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystContineum Therapeutics, Inc.: Q3 FY2026 results, three months to Sep 30, 2026, from an SEC filing. Read it →Latest filingSC 13G/APassive 5%+ stake updatedNov 6, 2026 · 5 days agoThe company can keep selling new shares into the market. Size not stated in the filing.
Some filings did not state a size, so these are floors.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
6,518,905 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $100.0M in size · Priced at $15.34/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Stengone Carmine N. Officer | Sold (automatic/other) | -3K | sold 13% | 17K | $41K at $16.46 | Sep 8, 26 |
Stengone Carmine N. Officer | Other | 3K | added 15% | 20K | $3K at $1.01 | Sep 8, 26 |
Stengone Carmine N. Officer | Sold (automatic/other) | -3K | sold 13% | 17K | $40K at $16.01 | Aug 3, 26 |
Stengone Carmine N. Officer | Other | 3K | added 15% | 20K | $3K at $1.01 | Aug 3, 26 |
Lorrain Daniel S. Officer | Sold (automatic/other) | -25 | sold <0.1% | 135K | $400 at $16.00 | Jul 9, 26 |
Lorrain Daniel S. Officer | Other | 25 | added <0.1% | 135K | $25 at $1.01 | Jul 9, 26 |
Stengone Carmine N. Officer | Sold (automatic/other) | -3K | sold 13% | 17K | $40K at $16.00 | Jul 8, 26 |
Stengone Carmine N. Officer | Other | 3K | added 15% | 20K | $3K at $1.01 | Jul 8, 26 |
Lorrain Daniel S. Officer | Sold (automatic/other) | -1K | sold 0.7% | 135K | $16K at $16.00 | Jul 8, 26 |
Lorrain Daniel S. Officer | Other | 1K | added 0.8% | 136K | $1K at $1.01 | Jul 8, 26 |
Lorrain Daniel S. Officer | Sold (automatic/other) | -8K 0.02% of company | sold 5.8% | 135K | $131K at $15.67 | Jul 1, 26 |
Lorrain Daniel S. Officer | Other | 4K 0.01% of company | added 3.0% | 144K | $4K at $1.01 | Jul 1, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on CTNM from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CTNM today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
CTNM last traded at $10.79, up 2.13% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The CTNM Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CTNM 94 times in the last 30 days.
CTNM (Contineum Therapeutics, Inc. Class A Common Stock) trades on XNAS, with a market cap of about $397M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CTNM for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CTNM discussion
Sign in to ask a question or join the discussion.